Reaction Biology

Drug Discovery · Biotechnology
Has an LEI
Lately:1 news story in 90 daysFollow changes →

Facts

as of Nov 17, 2026

Reaction Biology offers a comprehensive spectrum of drug discovery CRO services including fee-for-service preclinical drug testing and integrated drug discovery.

Headquarters
Malvern, United States
Founded
2001
Website
reactionbiology.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 4 cities in 2 countries.

4Cities
2Countries
Loading the map
SiteTypeOpen rolesHires most forEngineering
Malvern United StatesHeadquarters0
Freiburg im Breisgau GermanyRegional office0
Heidelberg GermanyRegional office0
Hershey United StatesRegional office0
Source: office addresses in postings and company registers

Financials

3 public grants on record, $3.3M in total.

$3.3MPublic grants3 public grants
Money by yearUSD, rounds and grants
2017$1.6M1 record
2016$1.7M2 records
Largest rounds and grants
2017
$1.6M
2016
$1.5M
2016
$248k
Sources: funding announcements, grant and company registers

Milestones

Feb 1, 2017
Won a grant $1.6M · CORDIS
Apr 1, 2016
Won a grant $248k · CORDIS
Each milestone is dated by its source: registers, filings, the press

Newsroom

Sep 82026
Blog
Why Kinase Selectivity Demands Multiple Assay Formats The human kinome comprises more than 500 kinases sharing a conserved ATP-binding pocket and high structural homology. This c…
Aug 12026
Blog
Participants: Haiching Ma, PhD (Founder & CSO, Reaction Biology), Jason Amsbaugh, MBA (CEO, Samba Scientific), Trent Carrier, PhD, MBA (CEO, Carolina Molecular) Overview Reaction…
Jul 272026
Blog
Headlines In This Issue Scientific Spotlight Our biochemical kinase platform, including HotSpot and ³³PanQinase, comprise the largest kinase library in the industry. Featured Res…
May 152026
Blog
Headlines In This Issue Scientific Spotlight: Immuno-Oncology Explore how tumor-associated macrophages influence therapeutic outcomes and why comprehensive preclinical models are…
Mar 262026
Blog
Over 100 kinase inhibitors have now been approved by the FDA, transforming the treatment of cancer and other diseases.¹ Yet despite this progress, a key question remains underexp…
Feb 192026
Blog
Immunological impact across diseases Far more therapeutic areas involve immune regulation than traditional disease boundaries have suggested, leading to practical implications fo…
Sources: the outlets named on each headline, each story once